List of Excipients in API LIOTHYRONINE SODIUM
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing LIOTHYRONINE SODIUM
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Par Pharmaceutical Inc | TRIOSTAT | liothyronine sodium | 42023-120 | ALCOHOL | |
| Par Pharmaceutical Inc | TRIOSTAT | liothyronine sodium | 42023-120 | AMMONIA | |
| Par Pharmaceutical Inc | TRIOSTAT | liothyronine sodium | 42023-120 | ANHYDROUS CITRIC ACID | |
| Physicians Total Care Inc | CYTOMEL | liothyronine sodium | 54868-5058 | CALCIUM SULFATE | |
| Physicians Total Care Inc | CYTOMEL | liothyronine sodium | 54868-5058 | GELATIN | |
| Physicians Total Care Inc | CYTOMEL | liothyronine sodium | 54868-5058 | STARCH, CORN | |
| Physicians Total Care Inc | CYTOMEL | liothyronine sodium | 54868-5058 | STEARIC ACID | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing LIOTHYRONINE SODIUM
Detailed excipient profiles for LIOTHYRONINE SODIUM
Excipient focus: ALCOHOL
LIOTHYRONINE SODIUM drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| XGen Pharmaceuticals DJB Inc | liothyronine sodium | 39822-0151 |
| Par Pharmaceutical Inc | liothyronine sodium | 42023-120 |
| >Company | >Ingredient | >NDC |
LIOTHYRONINE SODIUM drug variants not containing ALCOHOL
Excipient focus: AMMONIA
LIOTHYRONINE SODIUM drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| XGen Pharmaceuticals DJB Inc | liothyronine sodium | 39822-0151 |
| Par Pharmaceutical Inc | liothyronine sodium | 42023-120 |
| >Company | >Ingredient | >NDC |
LIOTHYRONINE SODIUM drug variants not containing AMMONIA
Excipient focus: ANHYDROUS CITRIC ACID
LIOTHYRONINE SODIUM drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| XGen Pharmaceuticals DJB Inc | liothyronine sodium | 39822-0151 |
| Par Pharmaceutical Inc | liothyronine sodium | 42023-120 |
| >Company | >Ingredient | >NDC |
LIOTHYRONINE SODIUM drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: CALCIUM SULFATE
LIOTHYRONINE SODIUM drug variants containing CALCIUM SULFATE
LIOTHYRONINE SODIUM drug variants not containing CALCIUM SULFATE
Excipient focus: CALCIUM SULFATE DIHYDRATE
LIOTHYRONINE SODIUM drug variants containing CALCIUM SULFATE DIHYDRATE
LIOTHYRONINE SODIUM drug variants not containing CALCIUM SULFATE DIHYDRATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
LIOTHYRONINE SODIUM drug variants containing CELLULOSE, MICROCRYSTALLINE
LIOTHYRONINE SODIUM drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
LIOTHYRONINE SODIUM drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| American Health Packaging | liothyronine sodium | 60687-625 |
| Sun Pharmaceutical Industries Inc | liothyronine sodium | 62756-589 |
| Bryant Ranch Prepack | liothyronine sodium | 63629-8337 |
| Bryant Ranch Prepack | liothyronine sodium | 71335-1671 |
| >Company | >Ingredient | >NDC |
LIOTHYRONINE SODIUM drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: EDETATE DISODIUM
LIOTHYRONINE SODIUM drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | liothyronine sodium | 0093-2179 |
| >Company | >Ingredient | >NDC |
LIOTHYRONINE SODIUM drug variants not containing EDETATE DISODIUM
Excipient focus: GELATIN
LIOTHYRONINE SODIUM drug variants containing GELATIN
LIOTHYRONINE SODIUM drug variants not containing GELATIN
Excipient focus: GELATIN TYPE B BOVINE
LIOTHYRONINE SODIUM drug variants containing GELATIN TYPE B BOVINE
| Company | Ingredient | NDC |
|---|---|---|
| American Health Packaging | liothyronine sodium | 60687-625 |
| Sun Pharmaceutical Industries Inc | liothyronine sodium | 62756-589 |
| Bryant Ranch Prepack | liothyronine sodium | 63629-8337 |
| Bryant Ranch Prepack | liothyronine sodium | 71335-1671 |
| >Company | >Ingredient | >NDC |
LIOTHYRONINE SODIUM drug variants not containing GELATIN TYPE B BOVINE
Excipient focus: HYPROMELLOSE
LIOTHYRONINE SODIUM drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | liothyronine sodium | 51407-384 |
| Mayne Pharma Commercial LLC | liothyronine sodium | 51862-320 |
| >Company | >Ingredient | >NDC |
LIOTHYRONINE SODIUM drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSES
LIOTHYRONINE SODIUM drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | liothyronine sodium | 33261-964 |
| DIRECT RX | liothyronine sodium | 61919-239 |
| Carilion Materials Management | liothyronine sodium | 68151-0237 |
| Carilion Materials Management | liothyronine sodium | 68151-0238 |
| >Company | >Ingredient | >NDC |
LIOTHYRONINE SODIUM drug variants not containing HYPROMELLOSES
Excipient focus: MAGNESIUM STEARATE
LIOTHYRONINE SODIUM drug variants containing MAGNESIUM STEARATE
LIOTHYRONINE SODIUM drug variants not containing MAGNESIUM STEARATE
Excipient focus: MANNITOL
LIOTHYRONINE SODIUM drug variants containing MANNITOL
LIOTHYRONINE SODIUM drug variants not containing MANNITOL
Excipient focus: SILICON DIOXIDE
LIOTHYRONINE SODIUM drug variants containing SILICON DIOXIDE
LIOTHYRONINE SODIUM drug variants not containing SILICON DIOXIDE
Excipient focus: STARCH, CORN
LIOTHYRONINE SODIUM drug variants containing STARCH, CORN
LIOTHYRONINE SODIUM drug variants not containing STARCH, CORN
Excipient focus: STEARIC ACID
LIOTHYRONINE SODIUM drug variants containing STEARIC ACID
LIOTHYRONINE SODIUM drug variants not containing STEARIC ACID
Excipient focus: SUCROSE
LIOTHYRONINE SODIUM drug variants containing SUCROSE
LIOTHYRONINE SODIUM drug variants not containing SUCROSE
Excipient focus: TALC
LIOTHYRONINE SODIUM drug variants containing TALC
LIOTHYRONINE SODIUM drug variants not containing TALC
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
